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from bronchial secretions than in sputum samples. 
Nevertheless, the evaluation of this particular 
application of FBO has been limited, and few 
studies have been conducted in Latin America. 
In addition, according to guidelines established 
by the Peruvian National Tuberculosis Control 
Program,(2) the use of bronchoscopy is not to be 
included in the diagnostic workup of patients 
with clinical suspicion of SNPT; the suggested 
course of action is to wait for sputum culture 
results before a consultation with an expert, 
who will decide whether treatment should be 
initiated or not. The pragmatic evaluation of the 
In low- and middle-income countries, fiberoptic 
bronchoscopy (FBO) is typically indicated as a 
means of identifying infectious conditions.(1) 
However, access to the procedure is limited in 
resource-constrained settings, and it implies some 
risks; therefore, patient selection should be quite 
accurate in order to avoid unnecessary risk for 
the patients and the overburdening of medical 
staff and laboratories. One common indication 
for FBO has been the diagnosis of smear-negative 
pulmonary tuberculosis (SNPT). The decision to 
perform FBO is usually based on the premise that 
the bacillary load is higher in samples taken directly 
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Abstract
We evaluated the diagnostic yield of fiberoptic bronchoscopy for the diagnosis of smear-negative pulmonary 
tuberculosis in patients treated at a referral hospital in Lima, Peru. Of the 611 patients who underwent the 
procedure, 140 (23%) were diagnosed with tuberculosis based on the analysis of BAL samples. Being young 
and being male were significantly associated with positive cultures. In addition, 287 patients underwent post-
bronchoscopic sputum smear testing for AFB, the results of which increased the diagnostic yield by 22% over 
that obtained through the analysis of BAL samples alone. We conclude that the analysis of BAL samples and 
post-bronchoscopic sputum samples provides a high diagnostic yield in smear-negative patients suspected of 
having pulmonary tuberculosis.
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Resumo
Avaliamos o rendimento diagnóstico da fibrobroncoscopia óptica no diagnóstico de tuberculose pulmonar BAAR 
negativa em pacientes atendidos em um hospital de referência em Lima, Peru. Dos 611 pacientes submetidos 
ao procedimento, 140 (23%) foram diagnosticados com tuberculose com base nas amostras de LBA. Ser mais 
jovem e do sexo masculino foi associado a culturas positivas. Além disso, 287 pacientes tiveram baciloscopia 
de escarro após a broncoscopia, e os resultados aumentaram o rendimento diagnóstico em 22% em relação às 
amostras de lavado. Concluímos que amostras de lavado brônquico e de escarro pós-broncoscopia tiveram um 
bom rendimento diagnóstico nos pacientes com suspeita de tuberculose pulmonar BAAR negativa.
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The AFB smears of BAL samples were positive 
in 68 (49%) of the tuberculosis patients (Table 1). 
Positive cultures provided the diagnosis in 72 
additional cases, giving an incremental diagnostic 
yield over AFB smears of BAL samples of 106%.
The results of post-bronchoscopic sputum 
AFB smears were available for 278 patients. 
The comparison between AFB smears of post-
bronchoscopic sputum samples and those 
of BAL samples is shown in Table 2. The 
incremental diagnostic yield of AFB testing of 
post-bronchoscopic sputum smears over that 
of BAL smears was 19%. Cultures of post-
bronchoscopic samples were obtained for 30 
patients. Of those 30 cultures, 11 were positive 
in both post-bronchoscopy sputum and BAL 
samples, 3 were positive only in post-bronchoscopy 
sputum samples, and 2 were positive only in 
BAL samples.
Sputum cultures performed before the 
procedure were available for comparison in 
56 patients. Of those 56 patients, 14 were 
diagnosed with pulmonary tuberculosis, the 
diagnosis being based only on positive BAL 
samples in 8 and only on pre-procedure sputum 
cultures in 3. In the 3 remaining patients, BAL 
and pre-procedure sputum cultures were both 
positive.
Our results show that, in patients suspected 
of having SNPT, the diagnostic yield of AFB 
diagnostic yield of bronchoscopy is therefore 
a key element of generating evidence-based 
recommendations for the use of the procedure 
in cases of SNPT. The objective of our study 
was to evaluate the diagnostic value of FBO in 
patients with two negative sputum smears and 
clinical suspicion of pulmonary tuberculosis in 
routine clinical practice.
The study was carried out at the Hospital 
Nacional Hipólito Unanue, a referral hospital in 
Lima, Peru. Within the districts served by the 
hospital the incidence of tuberculosis is high, 
being up to 300/100,000 population in some 
areas.(3) The study was approved by the Research 
Ethics Committee of Hospital Nacional Hipólito 
Unanue.
We reviewed the results of AFB smears and 
mycobacterial cultures from bronchial aspirates 
of adult patients who underwent FBO between 
January of 2008 and December of 2009 due to 
clinical suspicion of tuberculosis and who had at 
least two negative AFB smears. The procedures 
were performed by trained pulmonologists. 
Samples obtained by BAL were decontaminated, 
stained with Ziehl-Neelsen, and cultured in Ogawa 
medium in accordance with national guidelines.(2) 
Pulmonary tuberculosis was defined as a positive 
AFB smear or a positive culture for M. tuberculosis 
in the BAL or sputum samples obtained within 
two weeks before or after the procedure. A 
secondary analysis was carried out in order to 
compare the BAL results with the results of the 
pre-procedure sputum culture (if available) and 
the post-bronchoscopic sputum sample analysis. 
The incremental diagnostic yield was defined 
as the number of additional diagnoses divided 
by the number of cases diagnosed times 100, 
and it was calculated for all three procedures.
During the study period, 632 patients 
underwent FBO. Of those, 21 patients were 
excluded: 6 because their sputum smears tested 
positive prior to the procedure, 6 because the 
samples were contaminated, and 9 because data 
were missing. Therefore, 611 patients were included 
in the analysis. The mean age of the patients 
was 41.98 ± 17.09 years. Most of the patients 
were male (56.5%). Pulmonary tuberculosis was 
diagnosed in 140 patients (22.9%). In comparison 
with the other patients, those diagnosed with 
tuberculosis were younger (31.8 vs. 45.2 years; 
p < 0.001) and more often male (65% vs. 54%; 
p = 0.02).
Table 1 - Comparison between the diagnostic yield 
of AFB and that of culture in BAL samples in patients 
suspected of having smear-negative pulmonary 
tuberculosis. Lima, Peru, 2008-2009.
Method Culture 
Method Positive Negative Total
AFB Positive 61 7 68
Negative 72 471 543
Total 133 478 611
Table 2 - Comparison of the diagnostic yield of 
direct testing for AFB in BAL samples and in post-
bronchoscopic sputum samples in patients suspected 
of having smear-negative pulmonary tuberculosis. 
Lima, Peru, 2008-2009.
Sample type
Post-bronchoscopy 
sputum
Sample type Positive Negative Total
BAL Positive 15 16 31
Negative 6 241 247
Total 21 257 278
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proportion of patients undergo sputum culture 
before undergoing FBO. This could be due to 
the lack of rapid sputum sample testing methods 
and the belief that BAL samples are superior to 
sputum samples. In addition, other methods 
for optimizing the yield of smear microscopy 
are not currently performed in routine clinical 
practice in Peru. In particular, sputum induction 
has been shown to be an effective method for 
the diagnosis of tuberculosis, with a high rate 
of agreement with bronchoscopy,(6) and this can 
avoid a significant number of procedures. However, 
this method has not been yet implemented.
Given the very low proportion of patients 
for whom sputum cultures were performed, 
either prior to or immediately after FBO, we 
cannot draw definitive conclusions regarding 
their utility. However, our results suggest that 
both types of cultures add value to BAL testing. 
We believe that pre-bronchoscopy sputum, 
BAL, and post-bronchoscopy sputum samples 
should all be cultured, although the utility of 
this approach has not been formally validated, 
and, from an operational point of view, this 
could overburden laboratories. In fact, laboratory 
facilities typically do not perform more than one 
culture per patient. However, considering that few 
patients undergo FBO and that the diagnostic 
yield of such an invasive procedure should be 
maximized, we believe that it is worthwhile to 
culture those samples. Further research on the 
value of these types of samples should be done 
under operational conditions in order to evaluate 
their true contribution. In addition, the use of 
liquid media and molecular methods, which can 
improve the sensitivity of bronchoscopic sample 
analysis, should also be investigated.(10)
In summary, FBO is a procedure with a 
good diagnostic yield in patients suspected of 
having SNPT in a high incidence setting, such 
as ours. It is reasonable to perform at least 
one post-bronchoscopy sputum smear test in 
addition to BAL testing. The routine culture of 
pre-bronchoscopy sputum samples (including 
induced sputum samples) and post-bronchoscopy 
sputum samples seems to be useful and should 
be the object of future studies.
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smears and cultures from BAL samples is high, 
having the potential to diagnose tuberculosis in 
1 out of 4 patients undergoing FBO. This might 
even be an underestimation, considering that we 
used only solid culture media, which have low 
sensitivity in comparison with other media.(4,5) 
Another Latin American study in an HIV-prevalent 
setting also reported a good diagnostic yield from 
the procedure.(6) Nevertheless, the procedure is 
not included in the diagnostic workup of SNPT 
by the Peruvian Tuberculosis Control Program(2) 
or by the World Health Organization.(4)
One remarkable finding of the present study 
was the high frequency of tuberculosis among 
young male patients. This probably does not mean 
that the procedure is better for this age group 
but might rather reflect the higher prevalence 
of tuberculosis among such individuals.
Another interesting result was the high 
positivity of post-bronchoscopic sputum 
samples, which increased the diagnostic yield 
by approximately 20%. Although the analysis 
of post-bronchoscopy sputum samples has 
already been shown to have a good diagnostic 
yield in settings other than Latin America, the 
increase in diagnostic yield in previous studies 
was found to be close to 7%.(7) It is also of 
note that post-bronchoscopy sputum samples 
are currently sent for AFB smears but not for 
culture. In the few patients for whom cultures 
were performed in post-bronchoscopy samples, 
the cultures appeared to increase the diagnostic 
yield. However, because of the small size of our 
study sample, we could not explore this hypothesis 
further. Other limitations of our study are the 
retrospective nature of data collection, which 
might generate bias due to missing data, and the 
relatively short follow-up period (which might 
preclude the diagnosis of additional SNPT cases 
among those with negative AFB and culture 
results from BAL samples). In addition, we were 
not able to perform transbronchial biopsies, 
which have been shown to increase the sensitivity 
of the procedure from 25% to 40%.(8,9) Unless 
contraindicated, we believe that transbronchial 
biopsies should be performed in all patients who 
undergo FBO for the diagnosis of tuberculosis.
It is worrisome that, in routine clinical 
practice—despite the recommendations of the 
Peruvian National Tuberculosis Control Program, 
which stipulate that, after two negative sputum 
samples, a culture should be performed—a very low 
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